The International Journal of Tuberculosis and Lung Disease

Computed tomography scanning for lung cancer screening: an update [Editorial]
pp. 789-791(3)
Author: Goodman, Philip C.

Advances in treatment for non-small cell lung cancer [Editorial]
pp. 792-794(3)
Authors: Price, Katharine A.; Jett, James R.

Review of prescribing practices: an essential tool for measuring the quality of tuberculosis services [Editorial]
pp. 795-795(1)
Author: Norval, Pierre-Yves

Workplace spirometry monitoring for respiratory disease prevention: a methods review [State of the art]
pp. 796-805(10)
Authors: Hnizdo, E.; Glindmeyer, H. W.; Petsonk, E. L.

Impact of food and antacids on the pharmacokinetics of anti-tuberculosis drugs: systematic review and meta-analysis [Review article]
pp. 806-818(13)
Authors: Lin, M-Y.; Lin, S-J.; Chan, L-C.; Lu, Y-C.

Use of the QuantiFERON®-TB Gold test for screening tuberculosis contacts and predicting active disease
pp. 819-827(9)
Authors: Yoshiyama, T.; Harada, N.; Higuchi, K.; Sekiya, Y.; Uchimura, K.

Intra-assay reliability and robustness of QuantiFERON®-TB Gold In-Tube test in Zambia
pp. 828-833(6)
Authors: Shanaube, K.; De Haas, P.; Schaap, A.; Moyo, M.; Kosloff, B.; Devendra, A.; Raby, E.; Godfrey-Faussett, P.; Ayles, H.

Evaluation of QuantiFERON®-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment
pp. 834-840(7)
Authors: Sauzullo, I.; Mengoni, F.; Scrivo, R.; Valesini, G.; Potenza, C.; Skroza, N.; Marocco, R.; Lichtner, M.; Vullo, V.; Mastroianni, C. M.

Rapid detection of immunoglobulin G against Mycobacterium tuberculosis antigens by two commercial ELISA kits
pp. 841-846(6)
Authors: Ben Selma, W.; Harizi, H.; Marzouk, M.; Ben Kahla, I.; Ben Lazreg, F.; Ferjeni, A.; Harrabi, I.; Abdelghani, A.; Ben Said, M.; Boukadida, J.

Efficient mycobacterial DNA extraction from clinical samples for early diagnosis of tuberculosis
pp. 847-851(5)
Authors: Kumar, M.; Sharma, S.; Ram, A. B.; Khan, I. A.

Real-time polymerase chain reaction in bronchial aspirate for rapid detection of sputum smear-negative tuberculosis
pp. 852-858(7)
Authors: Min, J-W.; Yoon, H. I.; Park, K. U.; Song, J-H.; Lee, C-T.; Lee, J. H.

Factors associated with the high tuberculosis case rate in an urban area
pp. 859-865(7)
Authors: de Vries, G.; van Hest, N. A. H.; Baars, H. W. M.; Šebek, M. M. G. G.; Richardus, J. H.

Mortality in successfully treated tuberculosis patients in southern Ethiopia: retrospective follow-up study
pp. 866-871(6)
Authors: Datiko, D. G.; Lindtjørn, B.

Diagnosis and outcome of childhood tuberculosis: implementing public health policy in three districts of Pakistan
pp. 872-877(6)
Authors: Safdar, N.; Hinderaker, S. G.; Baloch, N. A.; Enarson, D.; Khan, M. A.; Morkve, O.

Inconsistent dosing of anti-tuberculosis drugs in Taipei, Taiwan
pp. 878-883(6)
Authors: Chiang, C-Y.; Bai, K-J.; Lee, C-N.; Enarson, D. A.; Suo, J.; Luh, K-T.

Availability of second-line drugs and anti-tuberculosis drug susceptibility testing in China: a situational analysis
pp. 884-889(6)
Authors: He, G. X.; van den Hof, S.; Borgdorff, M. W.; van der Werf, M. J.; Cheng, S. M.; Hu, Y. L.; Zhang, L. X.; Wang, L. X.

Evaluation of seven tests for the rapid detection of multidrug-resistant tuberculosis in Uganda
pp. 890-895(6)
Authors: Bwanga, F.; Joloba, M. L.; Haile, M.; Hoffner, S.

Factors associated with human immunodeficiency virus testing among tuberculosis patients receiving treatment at health facilities in Uganda
pp. 896-902(7)
Authors: Nabbuye-Sekandi, J.; Okot-Chono, R.; Rusen, I. D.; Dlodlo, R. A.; Katamba, A.; Tumwesigye, N. M.; Fujiwara, P. I.

Low uptake of antiretroviral therapy after admission with human immunodeficiency virus and tuberculosis in KwaZulu-Natal, South Africa
pp. 903-908(6)
Authors: Murphy, R. A.; Sunpath, H.; Taha, B.; Kappagoda, S.; Maphasa, K. T. M.; Kuritzkes, D. R.; Smeaton, L.

Human immunodeficiency virus increases the risk of tuberculosis due to recent re-infection in individuals with latent infection
pp. 909-915(7)
Authors: Houben, R. M. G. J.; Glynn, J. R.; Mallard, K.; Sichali, L.; Malema, S.; Fine, P. E. M.; French, N.; Crampin, A. C.

Human leukocyte antigen typing in tuberculous rheumatism: Poncet's disease
pp. 916-920(5)
Authors: Lugo-Zamudio, G. E.; Yamamoto-Furusho, J. K.; Delgado-Ochoa, D.; Nuñez-Farfán, R. M.; Vargas-Alarcón, G.; Barbosa-Cobos, R. E.; Granados, J.

Provider-initiated testing and counselling for human immunodeficiency virus among tuberculosis patients in Guangxi [Notes from the field]
pp. 921-923(3)
Authors: Wang, X-W.; Liu, Y.; Dong, B-Q.; Liu, F-Y.; Chen, Q.

Molecular epidemiology of multidrug-resistant Mycobacterium tuberculosis in Eastern Taiwan [Short communication]
pp. 924-926(3)
Authors: Hsu, A-H.; Lin, C-B.; Lee, Y-S.; Chiang, C-Y.; Chen, L-K.; Tsai, Y-S.; Lee, J-J.

Adequacy of 6-month follow-up in chemotherapy trials [Correspondence]
pp. 927-927(1)
Authors: Marais, B. J.; van Helden, P. D.; Donald, P. R.

In reply to ‘Adequacy of 6-month follow-up in chemotherapy trials’ [Correspondence]
pp. 928-928(1)
Authors: Nunn, Andrew J.; Phillips, Patrick P. J.; Mitchison, Denis A.

Timing of relapse after cessation of anti-tuberculosis chemotherapy [Correspondence]
pp. 928-928(1)
Author: Rieder, Hans L.

Adrenal crisis during anti-tuberculosis treatment [Correspondence]
pp. 929-930(2)
Authors: Guglielmetti, Lorenzo; Conti, Michela; Grigolo, Chiara; Cazzadori, Angelo; Concia, Ercole

Do corticosteroids prevent the paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome? [Correspondence]
pp. 930-930(1)
Authors: Luzzati, Roberto; Cavinato, Silvia; Giacomazzi, Donatella